| Literature DB >> 22448204 |
Mary Cardosa, Zubaidah Jamil Osman, Michael Nicholas, Lois Tonkin, Amanda Williams, Khuzaimah Abd Aziz, Ramli Mohd Ali, Norhana Mohd Dahari.
Abstract
Self-management of chronic illnesses has been widely recognised as an important goal on quality of life, health service utilisation and cost grounds. This study describes the first published account on the application of this approach to people suffering from chronic pain conditions in a Southeast Asian country, Malaysia. A heterogeneous sample of chronic pain patients in Malaysia attended a 2-week cognitive-behavioural pain management programme (PMP) aimed at improving daily functional activities and general psychological well-being. Complete datasets from 70 patients out of 102 patients who attended 11 programmes conducted from 2002 to 2007, as well as the 1-month and 1-year follow-up sessions at the hospital clinic, are reported. The pre- to post-treatment results on self-report measures indicate that significant gains were achieved on the dimensions of pain, disability and psychological well-being. These gains were maintained at both 1-month and 1-year follow-ups. The results mirror those reported from similar interventions in Europe and North America and indicate the concept of self-management of a chronic illness is acceptable and meaningful to Asian patients. Importantly, the achieved outcomes were independent of gender and ethnic group status.Entities:
Year: 2011 PMID: 22448204 PMCID: PMC3291846 DOI: 10.1007/s13142-011-0095-2
Source DB: PubMed Journal: Transl Behav Med ISSN: 1613-9860 Impact factor: 3.046
Socio-demographic details of MENANG participants according to their presence at 1-year follow-up
| Variables | Present at 1-year follow-up, | Not present at 1-year follow-up, |
|
|---|---|---|---|
| Age | 0.55ns | ||
| Mean (SD) | 42.87 (9.87) | 41.75 (9.45) | |
| Duration of pain (months) | 0.13ns | ||
| Mean (SD) | 72.06 (70.07) | 55.35 (52.88) | |
| Gender | 1.15ns | ||
| Male | 25 (35.7) | 15 (46.5) | |
| Female | 45 (64.3) | 17 (53.1) | |
| Ethnic group [ | 2.15ns | ||
| Malay | 26 (37.1) | 8 (25) | |
| Chinese | 3 (12.9) | 6 (21.9) | |
| Indian | 35 (50) | 17 (53.1) | |
| Relationship status [ | 3.29ns | ||
| In a relationship (married) | 54 (77.1) | 23 (71.9) | |
| Not in a relationship (single, separated, divorced) | 16 (22.9) | 9 (28.1) | |
| Educational level [ | 5.66ns | ||
| None and primary | 9 (12.5) | 10 (31.3) | |
| Secondary (O levels equivalent) | 39 (55.7) | 14 (43.8) | |
| Certificate/Diploma/STPM (A Levels) | 15 (21.4) | 4 (12.5) | |
| University Degree | 7 (10) | 4 (12.5) | |
| Pain sites [ | 1.63ns | ||
| Head, face, mouth | 4 (5.7) | 1 (3.1) | |
| Neck and upper limb | 15 (21.4) | 7 (21.9) | |
| Back/sacrum/buttock & lower limb | 38 (54.3) | 20 (62.5) | |
| Abdomen, pelvis, chest | 11 (15.7) | 4 (12.5) | |
| Two or more major pain sites | 2 (2.9) | 0 | |
| Pain types [ | 4.47ns | ||
| Neuropathic | 5 (20) | 7 (15.9) | |
| Musculoskeletal | 10 (40) | 28 (63.6) | |
| Mixed, neuropathic and musculoskeletal | 4 (16) | 5 (11.4) | |
| Visceral, mixed visceral and musculoskeletal | 6 (24) | 4 (9.1) | |
| | 70 (68.6) | 32 (31.4) |
Mean (SD), F values and effect sizes of outcome measures at post- treatment, 1-year and 1-month follow-up
| Measure (score range) | Pre-treatment | Post-treatment | 1 month | 1 year |
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Pain (0–10) | 6.71 (1.64) | 5.59 (1.75) | 5.20 (1.29) | 5.22 (1.35) | 17.63*** | 0.7 | 0.9 | 0.9 |
| Disability (R&M) | 14.48 (5.3) | 8.43 (6.52) | 6.26 (5.65) | 7.26 (6.2) | 55.42*** | 1.2 | 1.5 | 1.3 |
| DASS (0–42) depression | 14.96 (10.20) | 8.68 (8.76) | 5.90 (6.58) | 6.06 (7.89) | 21.39*** | 0.6 | 0.9 | 0.8 |
| Self-efficacy (PSEQ) (0–60) | 32.30 (14.13) | 44.90 (12.41) | 45.22 (10.45) | 45.75 (11.18) | 26.5*** | 0.8 | 0.9 | 0.9 |
| Catastrophising (PRSS) (0–5) | 2.75 (1.14) | 1.86 (1.28) | 1.50 (1.04) | 1.61 (1.04) | 22.43*** | 0.8 | 1.1 | 1.0 |
d 1 Effect size from pre-treatment to post-treatment; d 2 Effect size from pre-treatment to 1-month follow-up; d 3 Effect size from pre-treatment to 1-year follow-up
***p < 0.0005